Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Arbyn

Showing results (91-100 of 308) with videos related to

Pageof 31
Sort By:
Cancer Cytopathology|June 16, 2012
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysisJolien Roelens, Miriam Reuschenbach, Magnus von Knebel Doeberitz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 16, 2006
European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey)Marc Arbyn, Gokhan Tulunay, Nejat Ozgul, et al.
Journal of Cellular and Molecular Medicine|January 27, 2009
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rateMarc Arbyn, Pierre Martin-Hirsch, Frank Buntinx, et al.
BMJ Open|April 27, 2016
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)Grazyna Stanczuk, Gwendoline Baxter, Heather Currie, et al.
Journal of Virological Methods|March 26, 2021
Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT frameworkDitte Møller Ejegod, Helle Pedersen, Wim Quint, et al.
Diagnostic Microbiology and Infectious Disease|May 10, 2016
Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samplesArdashel Latsuzbaia, Jessica Tapp, Trung Nguyen, et al.
Cancer Epidemiology|September 10, 2019
Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in LuxembourgArdashel Latsuzbaia, Marc Arbyn, Jessica Tapp, et al.
Cancer Epidemiology|November 17, 2016
Enrolment of young women attending cervical cancer screening to survey effectiveness of HPV vaccinationMarc Arbyn, Davy Vanden Broeck, Johannes Bogers, et al.
Obstetrics and Gynecology|January 1, 2008
Liquid compared with conventional cervical cytology: a systematic review and meta-analysisMarc Arbyn, Christine Bergeron, Paul Klinkhamer, et al.
Journal of the National Cancer Institute|February 19, 2004
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasiaMarc Arbyn, Frank Buntinx, Marc Van Ranst, et al.
Pageof 31

Showing results (91-100 of 308) with videos related to

Sort By:
Pageof 31
Cancer Cytopathology|June 16, 2012
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysisJolien Roelens, Miriam Reuschenbach, Magnus von Knebel Doeberitz, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 16, 2006
European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey)Marc Arbyn, Gokhan Tulunay, Nejat Ozgul, et al.
Journal of Cellular and Molecular Medicine|January 27, 2009
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rateMarc Arbyn, Pierre Martin-Hirsch, Frank Buntinx, et al.
BMJ Open|April 27, 2016
Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)Grazyna Stanczuk, Gwendoline Baxter, Heather Currie, et al.
Journal of Virological Methods|March 26, 2021
Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT frameworkDitte Møller Ejegod, Helle Pedersen, Wim Quint, et al.
Diagnostic Microbiology and Infectious Disease|May 10, 2016
Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samplesArdashel Latsuzbaia, Jessica Tapp, Trung Nguyen, et al.
Cancer Epidemiology|September 10, 2019
Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in LuxembourgArdashel Latsuzbaia, Marc Arbyn, Jessica Tapp, et al.
Cancer Epidemiology|November 17, 2016
Enrolment of young women attending cervical cancer screening to survey effectiveness of HPV vaccinationMarc Arbyn, Davy Vanden Broeck, Johannes Bogers, et al.
Obstetrics and Gynecology|January 1, 2008
Liquid compared with conventional cervical cytology: a systematic review and meta-analysisMarc Arbyn, Christine Bergeron, Paul Klinkhamer, et al.
Journal of the National Cancer Institute|February 19, 2004
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasiaMarc Arbyn, Frank Buntinx, Marc Van Ranst, et al.
Pageof 31